← The Oversight Wall
LOW secondary Disclosure Gap

Carol D. Miller has not publicly weighed in on STOCK Act violation — failure to disclose husband's stock trades in pharmaceutical and defense companies

Carol D. Miller has accepted documented donations from sectors with material interests in "STOCK Act violation — failure to disclose husband's stock trades in pharmaceutical and defense companies" but has no public statement, vote, or hearing record on the topic. Expected position: As a member of the House Ways and Means Committee with jurisdiction over taxation, healthcare, and trade, Miller would be expected to promptly address her violation of federal transparency law requiring disclosure of stock trades by herself or her spouse within 45 days. Evidence of activity on adjacent topics: Miller failed for nearly a year to disclose 21 of her husband's stock trades cumulatively worth $217,021–$805,000. The trades included pharmaceutical giant Johnson & Johnson, Quest Diagnostics, Gilead Sciences, Clorox, and defense contractors General Dynamics and L3Harris. When confronted by Business Insider, her communications director acknowledged the late trades and attributed them to a 'technical error.' Miller was active on social media and in committee throughout this period but made no proactive public statement about the violation. She did not respond to requests for comment from multiple outlets about the STOCK Act violation. Primary URL: https://www.businessinsider.com/congress-carol-miller-stock-trades-investments-2022-9 Days silent: 614. The constituent is owed an explanation of the official's position.

Entities involved: Carol D. Miller
Detected: 01 May 2026
Evidence last verified: —
Supporting evidence
No directly attached facts; this gap is derived from connections and structural patterns. See the methodology for how that works.
3 actions you can take
Contact the oversight body
Ask the House Committee on Oversight and Government Reform to hold a hearing
Target: House Committee on Oversight and Government Reform
▸ Preview the prefilled message
Subject: Constituent request: hearing on Carol D. Miller has not publicly weighed in on STOCK Act violation — failure to disclose husband's stock trades in pharm

Dear Members of the House Committee on Oversight and Government Reform,

I am writing to ask the committee to hold a public hearing on the following matter that falls within your jurisdiction: Carol D. Miller has not publicly weighed in on STOCK Act violation — failure to disclose husband's stock trades in pharm.

The basis of this request is documented in publicly available evidence summarised here: Carol D. Miller has not publicly weighed in on STOCK Act violation — failure to disclose husband's stock trades in pharmaceutical and defense companies.

Full evidence trail with source citations:…
Open this action →
Tip a journalist
Send this to The Lever
Target: The Lever (David Sirota et al.)
▸ Preview the prefilled message
Subject: Tip — Carol D. Miller has not publicly weighed in on STOCK Act violation — failure to disclose husband's stock trades in pharmaceutical and defense companies

Hi The Lever team,

Tipping you to a documented accountability gap that aligns with your beat (Money in politics, regulatory capture):

Carol D. Miller has not publicly weighed in on STOCK Act violation — failure to disclose husband's stock trades in pharmaceutical and defense companies

One-line summary: Carol D. Miller has not publicly weighed in on STOCK Act violation — failure to disclose husband's stock trades in pharmaceutical and defense companies

Full evidence trail with source citations and confidence labels: https://goblinhouse.net/wall/disclosure-gap-congress-m001205-stock-act-viol…
Open this action →
Support a watchdog
Support Campaign Legal Center, who has jurisdiction over this
Target: Campaign Legal Center
Open this action →
Read how the Oversight Wall derives gaps and what it deliberately does not do — methodology. If you are the subject of this gap or believe the underlying evidence is wrong, please use our corrections process.